Search research articles
Contact Us
Filters
Showing results (821-830 of 1,123) with videos related to
Page
of 113
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 17, 2017
Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation
Swantje Völler, Robert B Flint, Leo M Stolk, et al.
Alimentary Pharmacology & Therapeutics
|
August 27, 2019
Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child
Jolien J M Freriksen, Minou van Seyen, Ali Judd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 7, 2012
Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms
Philippe R Mutwa, Quirine Fillekes, Marie Malgaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 16, 2005
Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy
Pieter L A Fraaij, Gwenda Verweel, Annemarie M C van Rossum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 10, 2004
Nelfinavir plasma concentrations are low during pregnancy
Jeannine F J B Nellen, Igor Schillevoort, Ferdinand W N M Wit, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2022
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer
Nikki de Rouw, Merel de Boer, René J Boosman, et al.
Clinical Pharmacokinetics
|
April 24, 2016
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Guillemette E Benoist, Rianne J Hendriks, Peter F A Mulders, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 2019
Protein binding of rifampicin is not saturated when using high-dose rifampicin
Carlijn H C Litjens, Rob E Aarnoutse, Eleonora W J van Ewijk-Beneken Kolmer, et al.
Clinical Pharmacokinetics
|
January 9, 2021
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis
Nikki de Rouw, Rene J Boosman, Alwin D R Huitema, et al.
Therapeutic Drug Monitoring
|
August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir
P W Hugen, D M Burger, M de Graaff, et al.
Page
of 113
Search research articles
Search
Showing results (821-830 of 1,123) with videos related to
Sort By:
Page
of 113
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 17, 2017
Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation
Swantje Völler, Robert B Flint, Leo M Stolk, et al.
Alimentary Pharmacology & Therapeutics
|
August 27, 2019
Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child
Jolien J M Freriksen, Minou van Seyen, Ali Judd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 7, 2012
Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms
Philippe R Mutwa, Quirine Fillekes, Marie Malgaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 16, 2005
Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy
Pieter L A Fraaij, Gwenda Verweel, Annemarie M C van Rossum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 10, 2004
Nelfinavir plasma concentrations are low during pregnancy
Jeannine F J B Nellen, Igor Schillevoort, Ferdinand W N M Wit, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2022
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer
Nikki de Rouw, Merel de Boer, René J Boosman, et al.
Clinical Pharmacokinetics
|
April 24, 2016
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Guillemette E Benoist, Rianne J Hendriks, Peter F A Mulders, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 2019
Protein binding of rifampicin is not saturated when using high-dose rifampicin
Carlijn H C Litjens, Rob E Aarnoutse, Eleonora W J van Ewijk-Beneken Kolmer, et al.
Clinical Pharmacokinetics
|
January 9, 2021
Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis
Nikki de Rouw, Rene J Boosman, Alwin D R Huitema, et al.
Therapeutic Drug Monitoring
|
August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir
P W Hugen, D M Burger, M de Graaff, et al.
Page
of 113